Clinical Trial Update: Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating decitabine followed by donor lymphocyte infusion for relapse AML after allogeneic stem cell transplantation; the status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Decitabine (Decitabine)
• Donor Lymphocyte Infusion

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Recurrent Adult Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN